Source: Eur Respir J, 53 (1) 1801880; 10.1183/13993003.01880-2018
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Karen M. Olsson, Katrin Meyer, Dominik Berliner, Marius M. Hoeper. Development of hepatopulmonary syndrome during combination therapy for portopulmonary hypertension. Eur Respir J, 53 (1) 1801880; 10.1183/13993003.01880-2018

Member's Comments

No comment yet.

Related content which might interest you: Hepatopulmonary syndrome following portopulmonary hypertension Source: Eur Respir J 2007; 29: 1277-1280 Year: 2007 Liver transplantation in hepatopulmonary syndrome and portopulmonary hypertension Source: Annual Congress 2003 - Pulmonary-hepatic disorders (PHD) - recommendations of the PHD ERS Task Force for management of hepatopulmonary syndrome and portopulmonary hypertension Year: 2003 Portopulmonary hypertension and hepatopulmonary syndrome: a clinician-oriented overview Source: Eur Respir Rev 2012 21:223-233 Year: 2012 Association between portopulmonary hypertension and hepatopulmonary syndrome in cirrhotics, candidates to hepatic transplantation Source: Annual Congress 2003 - Pulmonary hypertension Year: 2003 The lung in liver disease: hepatopulmonary syndrome and portopulmonary hypertension Source: Eur Respir Monogr 2019; 86: 262-277 Year: 2019 Iloprost treatment in portopulmonary hypertension Source: Annual Congress 2008 - Pulmonary hypertension I Year: 2008 How should we treat portopulmonary hypertension? Source: Eur Respir J 2006; 28: 466-467 Year: 2006 Sildenafil treatment for portopulmonary hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 651s Year: 2006 Ambrisentan for therapy of portopulmonary hypertension (POPH): Update on safety and efficacy Source: Annual Congress 2012 - Pulmonary circulation: clinical PAH, registries and treatments Year: 2012 An autopsy case of portopulmonary hypertension associated with idiopathic portal hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II Year: 2013 Hepatopulmonary syndrome among patients of cirrhosis of liver and portal hypertension Source: Annual Congress 2007 - Pulmonary circulation Year: 2007 The hepatopulmonary syndrome Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=112 Year: 2005 The metabolic syndrome and pulmonary hypertension Source: Virtual Congress 2020 – Pulmonary vascular diseases Year: 2020 Experience with inhaled iloprost and bosentan in portopulmonary hypertension Source: Eur Respir J 2007; 30: 1096-1102 Year: 2007 Portopulmonary hypertension: a further clue to pathogenesis? Source: Annual Congress 2005 - Challenges in the biological understanding of pulmonary arterial hypertension Year: 2005 Sildenafil for patients with portopulmonary hypertension, candidates to hepatic transplant Source: Eur Respir J 2004; 24: Suppl. 48, 109s Year: 2004 Acute effects of inhaled iloprost in portopulmonary hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 547s Year: 2006 Sildenafil treatment for portopulmonary hypertension Source: Eur Respir J 2006; 28: 563-567 Year: 2006